0
0
New Delhi: India possesses an abundance of scientific talent and groundbreaking discoveries in biosciences. However, a significant challenge persists in translating these advancements into tangible solutions that improve lives. This hurdle, often referred to as the “valley of death,” demands more than just scientific prowess; it necessitates structural reforms, aligned incentives, and bold experimentation.
Dr. Anurag Agrawal, Dean of the Trivedi School of Biosciences at Ashoka University, emphasizes the importance of incentivizing translational impact alongside academic publishing to overcome this obstacle. He suggests streamlining bureaucratic processes, expanding initiatives like the Atal Innovation Mission, and establishing robust incubators to support both ideation and implementation.
Academia and Industry Collaboration
Dr. Agrawal advocates for nurturing a passion for innovation early on, before students become overly focused on exams and risk-averse. Ashoka University is actively fostering this vision by constructing an innovation center integrated with the Trivedi School of Biosciences, encouraging undergraduates to engage with cutting-edge technologies from the outset. The university’s Lodha Young Genius program further connects high school students with leading thinkers, aiming to ignite lifelong interests.
From Rare Diseases to Mainstream Health
India’s progress in genomics, initially driven by the diagnosis of pediatric rare diseases using next-generation sequencing (NGS), holds potential for broader applications, particularly in addressing prevalent non-communicable diseases (NCDs) like cancer. Companies such as Karkinos healthcare and Strand Life Sciences are working to democratize genomic diagnostics, potentially making precision oncology more accessible.
Genomic Surveillance
The COVID-19 pandemic underscored the critical need for genomic surveillance, while also exposing existing gaps. Dr. Agrawal stresses that effective surveillance must be embedded within public health systems, with strong federal coordination, and should be led by the government rather than relying solely on the private sector.
Precision Medicine
Dr. Agrawal promotes a more inclusive understanding of precision medicine, encompassing AI, mobile tech, and wearable devices to deliver personalized care to a wider population. He cautions that the benefits of genomic diagnostics are limited without affordable access to corresponding treatments, urging alignment between diagnostics, treatment availability, regulatory flexibility, and pricing reforms.
Dr. Agrawal suggests the National Research Foundation (NRF) prioritize investing in people and mentorship, rather than micromanaging outcomes. He believes that supporting passionate researchers and capable institutions will naturally lead to impactful results.
The Road Ahead
Unlocking the full potential of Indian biosciences requires a culture that values real-world outcomes, promotes interdisciplinary education, and supports translation at every stage. Dr. Agrawal envisions Ashoka University serving as a testing ground for innovative ideas that can be scaled nationally, emphasizing that India possesses the talent and technology needed to democratize health innovation.
Disclaimer: This article is based on the information provided in the source article. Any opinions expressed are those of the original author and do not necessarily reflect the views of this publication.
Citations:
